RNO 0.00% 4.0¢ rhinomed limited

Would the SP fall further?, page-13

  1. 4,567 Posts.
    lightbulb Created with Sketch. 793
    Information we have
    "Mute User Trials Late in 2014, the Company published results from an independently conducted user trial, with Mute™ achieving primary endpoints including a significant reduction in snoring severity, volume, frequency and duration. The trial (n=236) exceeded in pre-specified criteria and showed clear improvement in reported sleep quality in both snorers and partners. The trial involved five nights in-home with continual use. Importantly, 75% of subjects reported a reduction in snoring and 78% reported an improvement in breathing at night."

    Information that is coming.

    "Independent Trials An independent trial at Murdoch University (WA) School of Exercise Science under the leadership of Dr Jeremiah Peiffer was started at the end of the financial year. This trial seeks to show the impact of Turbine™ on athletes during a 20km time trial. Results are expected at the end of CY15. "

    ( All from 2015 annual report)

    What we now need to see is real sales data.
 
watchlist Created with Sketch. Add RNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.